Cergentis: Changes in Management Utrecht-based Cergentis announced the appointment of Joris Schuurmans as new CEO. more ➔
BioAscent strengthens US business Nick Moore now supports Scottish BioAscent Discovery Ltd. in further developing its business in North America. more ➔
Biognosys appoints new Chairman Schlieren-based proteomics specialist Biognosys AG announces the appointment of Dr Patrick Vink as Chairman of the board. more ➔
New CEO at IpsenDavid Loew, formerly executive vice president of Sanofi Pasteur, was appointed as CEO of French Ipsen Pharma SA at the beginning of July. more ➔
New Chief Business Officer for MaaT Pharma Dr Savita Bernal joined the Lyon-based MaaT Pharma as new Chief Business Officer. more ➔
Evox Therapeutics appoints Chief Medical O... Oxford-based Evox Therapeutics appoints Sonya Montgomery in the newly formed position of Chief Medical Officer. more ➔
Non-Executive Director for Redx Pharma From the beginning of July, Sarah Gordon Wild will be an Independent non-Executive Director at Redx Pharma in Alderley Park, UK. more ➔
Genentech: New Head of Research and Early... Aviv Regev will follow Michael Varney as Head of Genentech Research and Early Development (gRED) at Roche subsidiary Genentech. Varney will retire from the company at the end of July. more ➔
New CEO at Deinove Montpellier-based Deinove has named a new Chief Executive Officer. Alexis Rideau took over the helm of the company in the beginning of May. more ➔
From Novartis to Syncona London-based Syncona Ltd announces the appointment of Danny Bar-Zohar as Syncona Partner, starting mid of April. more ➔
